I think what differentiates TBI trials to Retts and FX is the use of biomarkers, and so probably a more "convincing" proof of efficacy in comparison to questionnaires or other non biological tests. Would also be proof of being an anti inflammatory which is the common cause of the many CNS disorders listed in the Annual Report.
So IMO this is the biggie...if a good result doesn't shake things up, nothing will...Good Luck to all
Ann: Annual Report to shareholders-NEU.AX, page-37
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$17.09 |
Change
0.000(0.00%) |
Mkt cap ! $2.184B | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 582 | $17.95 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $14.00 | 1600 | 1 |
View Market Depth
| Last trade - 16.36pm 07/08/2024 (20 minute delay) ? |
| NEU (ASX) Chart |
Day chart unavailable